Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.Financial_Report.xls
10-Q - GENESIS BIOPHARMA FORM 10-Q - Lion Biotechnologies, Inc.gnbp10q093012.htm
XML - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.R9.htm
XML - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.R8.htm
XML - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.R28.htm
XML - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.R25.htm
EX-31.2 - EXHIBIT 31.2 - Lion Biotechnologies, Inc.ex312.htm
EX-31.1 - EXHIBIT 31.1 - Lion Biotechnologies, Inc.ex311.htm
EX-32.1 - EXHIBIT 32.1 - Lion Biotechnologies, Inc.ex321.htm
EX-32.2 - EXHIBIT 32.2 - Lion Biotechnologies, Inc.ex322.htm
XML - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.R5.htm
XML - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.R4.htm
XML - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.R7.htm
XML - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.R1.htm
XML - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.R6.htm
XML - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.R3.htm
XML - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.R17.htm
XML - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.R18.htm
XML - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.R24.htm
XML - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.R10.htm
XML - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.R26.htm
XML - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.R20.htm
XML - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.R19.htm
XML - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.R23.htm
XML - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.R27.htm
XML - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.R14.htm
XML - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.R16.htm
XML - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.R13.htm
XML - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.R21.htm
XML - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.R22.htm
XML - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.R15.htm
XML - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.R11.htm
XML - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.R12.htm
v2.4.0.6
Condensed Balance Sheets (USD $)
Sep. 30, 2012
Dec. 31, 2011
Current Assets    
Cash and cash equivalents $ 0 $ 510,217
Deposits and prepaid expenses 5,000 13,864
Total current assets 5,000 524,081
Property and equipment, net of accumulated depreciation of $5,361 and $2,704 23,692 28,349
Rent Deposit 0 16,000
Total assets 28,692 568,430
Current Liabilities    
Accounts payable 841,616 190,048
Accrued expenses 1,011,498 221,507
Accrued expenses - National Institutes of Health 616,000 0
7% convertible promissory notes 5,000,000 5,000,000
12% secured promissory notes 1,231,250 0
September 2012 secured promissory note 250,000 0
Derivative liabilities 7,659,929 7,937,793
Total Current Liabilities 16,610,293 13,349,348
Stockholders' Deficiency    
Common stock, $0.000041666 par value; 1,800,000,000 shares authorized, 78,293,095 and 77,993,591 shares issued and outstanding, respectively 3,262 3,250
Common shares to be issued 497,888 0
Additional paid-in capital 17,067,685 14,592,408
Accumulated deficit (34,150,436) (27,376,576)
Total Stockholders' Deficiency (16,581,601) (12,780,918)
Total Liabilities and Stockholders' Deficiency $ 28,692 $ 568,430